Site search

Clear filter
2890 results for '' found
A Phase III Open-label, Randomised, Multicentre Study Comparing AZD0120, a Dual-Targeting Autologous Chimeric Antigen Receptor T-cell [CAR-T] Therapy Directed Against BCMA and CD19, versus Standard Re
/
A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory myop
/
A multicenter, randomized, double-blind, placebo-controlled, dose-range Phase II study to assess the efficacy and safety of GIA632 in patients with non-segmental vitiligo not adequately controlled wit
/
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess Efficacy, Safety and Tolerability of BMB-101 Oral Solution for the Treatment of Patients with Prader-Willi Syndrome [PWS] (NCT072
/
A Phase III, randomised, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronch
/
Sleep Clinic Patient Initiated Review Information Sheet pdf
Sleep_Clinic_Patient_Initiated_Review_Information_Sheet.pdf
Alfred Health GP News - April 2026 pdf
Alfred_Health_GP_News_-_April_2026.pdf
Cardiac Care at Home
Cardiac Care at Home
/services/cardiac-care-at-home
Minderoo Foundation Wellness Centre - Newsletter Apr 2026 pdf
Wellness_Centre_Newsletter_April_2026.pdf
The Alfred - Flexible Endoscopic Evaluation of Swallowing (FEES) PDF
https://app.prompt.org.au/download/261381?code=eb227d48-a984-43a0-9312-67f2095bc5a8
1 2 3 4